 - Patients with hematologic malignancies requiring hematopoietic stem cell transplantation: 1 high risk acute myeloid leukemia in remission, 2 high risk acute lymphoblastic leukemia in remission, or 3 IPSS intermediate-2, high, or transfusion-dependent myelodysplastic syndrome 